Results of two open-label phase I/II studies of stem cell-derived RPE treatments for retinal degeneration are published in the Lancet
Researchers based at the Jules Stein Eye Institute Retina Division and David Geffen School of Medicine, University of California, Los Angeles, have published the results… Read More »Results of two open-label phase I/II studies of stem cell-derived RPE treatments for retinal degeneration are published in the Lancet